Johnson & Johnson Cv Rx, Inc. Call Options Transaction History
Johnson & Johnson
- $290 Million
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CVRX
# of Institutions
83Shares Held
13.5MCall Options Held
49.9KPut Options Held
2.1K-
Nea Management Company, LLC Timonium, MD2.37MShares$36.6 Million2.68% of portfolio
-
Black Rock Inc. New York, NY876KShares$13.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA664KShares$10.2 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT587KShares$9.05 Million0.71% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT448KShares$6.9 Million0.79% of portfolio
About CVRx, Inc.
- Ticker CVRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 20,576,200
- Market Cap $317M
- Description
- CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...